氨溴索佐雾化吸入辅助治疗哮喘性支气管炎患者的临床效果

Analysis of Clinical Value of Ambroxol in the Treatment of Patients with Asthmatic Bronchitis

目的观察氨溴索雾化吸入治疗哮喘性支气管炎的效果。方法选取2018年1月至2019年2月淮安市淮安区皮肤病防治院收治的哮喘性支气管炎患者36例,以数字法随机分为两组,每组18例。对照组患者采取常规对症治疗,观察组在该基础上加用氨溴索雾化吸入进行辅助治疗。对比两组治疗效果。结果观察组的治疗总有效率为94.44%,对照组为77.78%,组间比较差异有统计学意义(P<0.05);观察组患者的咳嗽、哮鸣音、痰鸣音、湿啰音、喘息消退时间均短于对照组(P<0.05)。结论哮喘性支气管炎患者治疗中通过应用氨溴索进行辅助治疗,可显著提升临床疗效并缩短患者病程时间。

Objective To observe the efficacy of ambroxol nebulized inhalation in the treatment of asthmatic bronchitis.Methods Thirty-six patients with asthma bronchitis from January 2018 to February 2019 were randomly divided into two groups,18 in each group.The patients in the control group were treated with routine symptomatic treatment,while the observation group was treated with ambroxol nebulized inhalation on the basis of the control group.The therapeutic effects of the two groups were compared.Results The total effective rate was 94.44%in the observation group and 77.78%in the control group(P<0.05).The time of cough,wheeze,phlegm,wet rale and wheeze in the observation group was shorter than that in the control group(P<0.05).Conclusion The application of ambroxol in the treatment of asthmatic bronchitis can significantly improve the clinical efficacy and shorten the duration of the disease.